Sorry to hear this. It looks like this was caught early.
Erbitux has a different mechanism than cisplatin. It selectively targets a growth factor receptor.
It seems to be easier available these days, which makes sense it is a relatively new drug. I think it was approved for H&N cancer in 2006, either as combination with radiation or as a single drug. Also there have been studies using Erbitux together with traditional chemo therapy agents.

It may be possible to have IMRT again. Eve if you do not do this the possibility that is available is good.

M




Last edited by Markus; 09-03-2008 05:31 PM.
Partial glossectomy (25%) anterior tongue. 4/6/07/. IMRT start @5/24/07 (3x) Erbitux start/end@ 5/24/07. IMRT wider field (30x) start 6/5/07. Weekly cisplatin (2x30mg/m2), then weekly carbo- (5x180mg/m2). End of Tx 19 July 07.